“Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, intense surgical manipulation from the tumor's extent, may result in greater ...
A new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of ...
The study authors said the method also has the advantages of having a quick turnaround and a relatively low cost. The study authors noted that ALL is the most common pediatric malignancy, but in a ...
Whole-genome cell-free DNA (cfDNA) changes as a dynamic blood-based biomarker for early response assessment of advanced tumors. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I.
Cell-free DNA (cfDNA) can act as a powerful biomarker for cancer research, from disease onset to therapy selection and minimal residual disease (MRD) measurement. Next-generation sequencing (NGS) has ...
Next-generation sequencing (NGS) is an important component of first-line treatment selection for metastatic non–small-cell lung cancer (NSCLC) and is typically ordered by medical oncologists in the ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Early and accurate detection of rejection remains a major challenge in kidney transplantation, with clinicians still relying on decades-old indicators. There is a growing demand for more sensitive, ...
Clinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample time ...
High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA abundance Library preparation kit adds to Twist’s portfolio of tools to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results